Data Demonstrate Hygieia d-Nav® Insulin Guidance Service Generates Substantial Cost Savings By Optimizing Insulin and The Use of Glycemic Medications…
Data Demonstrate Hygieia d-Nav® Insulin Guidance Service Generates Substantial Cost Savings By Optimizing Insulin and The Use of Glycemic Medications Among People with Type 2 Diabetes
By a
"Insulin therapy is critical to the health of more than 6 million people in
Clinical practice guidelines generally point to hemoglobin A1c (HbA1c) levels below 7 percent as reasonable targets to help prevent diabetes complications. Standards for Medical Care in Diabetes published by the
All participants in the d-Nav Service Health Economic Evaluation used the d-Nav Service, and a total of 192 patients with type 2 diabetes completed the first 90 days. Prior to joining the study, nearly 30 percent of participants had been prescribed expensive glycemic medications as part of their treatment regimen.* Initial results from the evaluation show that the d-Nav Service enables optimization of glycemic medications for most patients, reducing the need for multiple medications (i.e., poly-therapy), while also reducing HbA1c by an average of 1.7 percentage points within 90 days.
Medication Cost Savings: In line with
"The cost savings demonstrated in this evaluation are substantial," said
Improved Glycemic Control: The average HbA1c among all 192 d-Nav Service study participants was 9.4 percent at study initiation; the average HbA1c at participants' 90-day visit was 7.7 percent - an average HbA1c decrease of 1.7 percentage points. This HbA1c reduction is expected to further reduce medical costs by an additional
"The likelihood of people with type 2 diabetes experiencing severe complications such as heart disease, heart failure, stroke and blindness increases significantly for each one percent increase in HbA1c," said Dr.
Patient Satisfaction: Study participants also reported high satisfaction with the d-Nav Service overall. Among 103 study patients who responded to a blinded participant survey, all but one said that they are more satisfied with their ability to manage diabetes and all 103 reported being more satisfied with their blood sugar control while supported by the d-Nav Service.
Three-year data from a similar demonstration project conducted by
Keywords for this news article include: Hygieia, Therapy, Proinsulin, Type 2 Diabetes, Peptide Hormones, Peptide Proteins, Health and Medicine, Risk and Prevention, Finance and Investment, Non-Insulin Dependent Diabetes Mellitus, Nutritional and Metabolic Diseases and Conditions.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
Validus Holdings Ltd Files SEC Form DEFA14A, Additional Definitive Proxy Soliciting Materials And Rule 14(A)(12) Material: (Jan. 22, 2018)
Global Reinsurance Providers Market Briefing 2018: Property & Casualty Reinsurance Providers, Life & Health Reinsurance Providers -…
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News